Skip to content

Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants

Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03638596
Enrollment
158
Registered
2018-08-20
Start date
2017-05-01
Completion date
2021-03-15
Last updated
2024-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drunk Driving

Keywords

Alcohol Impaired Driving, Driving While Intoxicated, Driving Under the Influence, Driving While Impaired

Brief summary

The current study will evaluate the efficacy of contingency management (i.e., reinforcement for avoiding heavy drinking) among adults arrested for drunk driving and who are at risk for ongoing heavy drinking.

Detailed description

Individuals who have a drunk driving arrest and are at risk for ongoing heavy drinking will be recruited to test the efficacy of contingency management for reducing alcohol use and identifying mechanisms of change. We will recruit those arrested for drunk driving offenses, ≥ 21 years of age, who at risk for ongoing heavy alcohol use and randomize them to one of two groups: control or a contingency management. Participants experience 8 weekly assessments of current alcohol use and other variables associated with changes in alcohol use. Post-intervention, participants will return to the laboratory once per month at 3, 6, 9, and 12 months post-study entry for follow-up procedures to determine the mechanisms of drinking behavior change.

Interventions

BEHAVIORALContingency Management

Incentive provided for changing alcohol drinking patterns based on ankle monitor

BEHAVIORALControl

Incentive provided is not contingent on alcohol drinking patterns based on ankle monitor

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

random assignment to treatment and control arms

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* arrested for drunk driving offense

Exclusion criteria

* significant alcohol withdrawal symptoms * medical condition that would contraindicate participation (e.g., pregnancy, scheduled surgery) * inability to comprehend the informed consent process or study instructions * presence of a DSM-5 psychiatric disorder with symptoms of psychosis and/or delirium * incarceration

Design outcomes

Primary

MeasureTime frameDescription
Percent heavy drinking days8-weeksPercent of days with estimated breath alcohol concentration .08% or higher or self-reported drinks \> 5 for men and \> 4 for women

Secondary

MeasureTime frameDescription
Percent drinking days8-weeksPercent of days with any positive transdermal alcohol concentration \>.02 or any self-reported drinks
Follow-up percent heavy drinking days12-monthsSelf-reported drinks \> 5 for men and \> 4 for women
Follow-up percent drinking days12-monthsAny self-reported drinks
Measurement of alcohol biomarkerBaseline to 8-weeksChange in phosphatidylethanol (PEth) using an assay on a blood sample

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026